{ "@context": "http:\/\/schema.org", "@type": "Article", "image": "https:\/\/sandiegouniontribune.noticiases.info\/wp-content\/s\/2024\/11\/SUT-L-BIO-RDP-1129-03.jpg?w=150&strip=all", "headline": "Pharma giant Roche to buy San Diego biotech for up to $1.5B", "datePublished": "2024-11-29 12:02:53", "author": { "@type": "Person", "workLocation": { "@type": "Place" }, "Point": { "@type": "Point", "Type": "Journalist" }, "sameAs": [ "https:\/\/sandiegouniontribune.noticiases.info\/author\/gqlshare\/" ], "name": "gqlshare" } } Skip to content
Pharmaceutical giant Roche agreed to acquire San Diego-based Poseida Therapeutics for up to $1.5 billion. (Courtesy of Roche)
(Courtesy of Roche)
Pharmaceutical giant Roche agreed to acquire San Diego-based Poseida Therapeutics for up to $1.5 billion. (Courtesy of Roche)
UPDATED:

Two San Diego biotechs struck big pharma deals each worth up to $1 billion, within one week.

Subscribe to continue reading this article.

Already subscribed? To , click here.

Originally Published:

RevContent Feed

Events